EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential Modifying Effect of the APOEε4 Allele on Age of Onset and Clinical Manifestations in Patients with Early-Onset Alzheimer’s Disease with and without a Pathogenic Variant in PSEN1 in a Sample of the Mexican Population

César A Valdez-Gaxiola iD, Eric Jonathan Maciel-Cruz iD, Rubiceli Hernández-Peña iD, Sofía Dumois-Petersen, Frida Rosales-Leycegui iD, Martha Patricia Gallegos-Arreola iD, José Miguel Moreno-Ortiz, Luis E Figuera iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von César A Valdez-Gaxiola und 7 weiteren Autor:innen. Beteiligte Einrichtung: División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara 44340, Jalisco, Mexico. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Fogarty NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Alzheimer’s disease (AD), the age of onset (AoO) exhibits considerable variability, spanning from 40 to 90 years. Specifically, individuals diagnosed with AD and exhibiting symptoms prior to the age of 65 are typically classified as early onset (EOAD) cases. Notably, the apolipoprotein E (APOE) ε4 allele represents the most extensively studied genetic risk factor associated with AD. We clinically characterized and genotyped the APOEε4 allele from 101 individuals with a diagnosis of EOAD, and 69 of them were affected carriers of the autosomal dominant fully penetrant PSEN1 variant c.1292C>A (rs63750083, A431E) (PSEN1+ group), while there were 32 patients in which the genetic cause was unknown (PSEN1− group). We found a correlation between the AoO and the APOEε4 allele; patients carrying at least one APOEε4 allele showed delays, in AoO in patients in the PSEN1+ and PSEN1− groups, of 3.9 (p = 0.001) and 8.6 years (p = 0.012), respectively. The PSEN1+ group presented higher frequencies of gait disorders compared to PSEN1− group, and apraxia was more frequent with PSEN1+/APOE4+ than in the rest of the subgroup. This study shows what appears to be an inverse effect of APOEε4 in EOAD patients, as it delays AoO and modifies clinical manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAdultAgedAged, 80 and overHumansMiddle AgedAge of OnsetAllelesApolipoprotein E4GenotypePresenilin-1Apolipoproteins E

Stichwörter der Autor:innen

age of onsetapolipoprotein Eclinical manifestationsearly-onset Alzheimer’s disease

Substanzen

Apolipoprotein E4Presenilin-1PSEN1 protein, humanApoE protein, humanApolipoproteins E

Autor:innen und Institutionen

  • División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara 44340, Jalisco, Mexico.
  • Doctorado en Genética Humana, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Maestría en Ciencias del Comportamiento, Instituto de Neurociencias, Centro Universitario de Ciencias Biológicas y Agropecuarias, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Instituto de Genética Humana "Dr. Enrique Corona Rivera", Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

ORCID-Profile: César A Valdez-Gaxiola, Eric Jonathan Maciel-Cruz, Rubiceli Hernández-Peña, Frida Rosales-Leycegui, Martha Patricia Gallegos-Arreola, Luis E Figuera

Förderung

  • FIC NIH HHS
  • Fogarty NIH

Zitieren

APA

Valdez-Gaxiola, C. A., Maciel-Cruz, E. J., Hernández-Peña, R., Dumois-Petersen, S., Rosales-Leycegui, F., Gallegos-Arreola, M. P., Moreno-Ortiz, J. M., & Figuera, L. E. (2023). Potential Modifying Effect of the APOEε4 Allele on Age of Onset and Clinical Manifestations in Patients with Early-Onset Alzheimer’s Disease with and without a Pathogenic Variant in PSEN1 in a Sample of the Mexican Population. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115687

Vancouver

Valdez-Gaxiola CA, Maciel-Cruz EJ, Hernández-Peña R, Dumois-Petersen S, Rosales-Leycegui F, Gallegos-Arreola MP, et al. Potential Modifying Effect of the APOEε4 Allele on Age of Onset and Clinical Manifestations in Patients with Early-Onset Alzheimer’s Disease with and without a Pathogenic Variant in PSEN1 in a Sample of the Mexican Population. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115687

BibTeX
@article{ValdezGaxiola2023,
  author = {Valdez-Gaxiola, César A and Maciel-Cruz, Eric Jonathan and Hernández-Peña, Rubiceli and Dumois-Petersen, Sofía and Rosales-Leycegui, Frida and Gallegos-Arreola, Martha Patricia and Moreno-Ortiz, José Miguel and Figuera, Luis E},
  title = {Potential Modifying Effect of the APOEε4 Allele on Age of Onset and Clinical Manifestations in Patients with Early-Onset Alzheimer’s Disease with and without a Pathogenic Variant in PSEN1 in a Sample of the Mexican Population},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115687}
}
Kostenlos starten →